Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.225
Bid: 1.15
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.15 (13.043%)
Open: 1.20
High: 1.30
Low: 1.30
Prev. Close: 1.225
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Feb 2010 07:00

RNS Number : 5796H
Chamberlin PLC
24 February 2010
 



24 February 2010

Chamberlin plc

("Chamberlin" or "the Company")

 

Director / PDMR Shareholding

 

 

The Company has today announced that the Board has approved the grant of options to the Executive Directors under the Chamberlin Share Option Plan (the "SOP"). At the same time the Directors will surrender all of their existing share options granted under the SOP, The Chamberlin & Hill Approved Share Plan (the "Approved Plan") and the Chamberlin & Hill Unapproved Share Plan (the "Unapproved Plan"). Tim Hair will also surrender some of his existing share options granted under The Chamberlin Performance Share Plan (the "PSP").

 

The Directors have been granted the following options:

 

Director

Number of options surrendered

Number of options retained under PSP*

Number of parallel options awarded under SOP*

Number of new options awarded under SOP

Total number of options

Tim Hair

Mark Bache

Adam Vicary

576,987

250,971

51,000

193,935

152,367

99,222

193,935

152,367

99,222

698,584

293,892

49,531

892,519

446,259

148,753

 

* The options retained under the PSP will be subject to the existing performance criteria as defined by the scheme. In the event that these options fail to vest, those SOP options awarded in parallel to the PSP scheme will become exercisable, subject to the performance conditions below. In the event that the PSP options are exercised the equivalent number of SOP options will be cancelled.

 

Excluding the parallel grant of SOP options, which is on an either/or basis with existing PSP options, in total 878,958 options are being surrendered and 1,042,007 new options issued. It remains the Company's intention to restrict the actual dilution of existing ordinary share capital to no more than 10% through the use of market purchased shares or cash in lieu of the exercise of options, in so far as this is prudently possible.

 

The SOP options are exercisable at a price of 52.8 pence each, based on the average closing mid-market price over the past 30 trading days, at any time between 23 February 2013 and 23 February 2020. They will vest subject to a TSR performance equivalent to achieving minimum share price of 100 pence on a theoretical no dividends basis (at which one third of the options will vest) up to a maximum price equivalent to 180p on the same basis at which all SOP options will vest, with vesting calculated on a straight line basis between these points. Performance will be tested over a period of three years from 23 February 2010.

 

The options surrendered by Tim Hair, Mark Bache and Adam Vicary were cancelled on 23 February 2010.

 

For further information:

 

Chamberlin plc T: 01922 707100

Tom Brown, Chairman

Tim Hair, Chief Executive

 

Charles Stanley Securities T: 020 7149 6000

Nominated Adviser

Russell Cook/Jen Boorer

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTJMLTMBMTBLM
Date   Source Headline
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.